Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Impaired complex I repair causes recessive Leber’s hereditary optic neuropathy
Sarah L. Stenton, et al.
Sarah L. Stenton, et al.
View: Text | PDF
Research Article Genetics Neuroscience

Impaired complex I repair causes recessive Leber’s hereditary optic neuropathy

  • Text
  • PDF
Abstract

Leber’s hereditary optic neuropathy (LHON) is the most frequent mitochondrial disease and was the first to be genetically defined by a point mutation in mitochondrial DNA (mtDNA). A molecular diagnosis is achieved in up to 95% of cases, the vast majority of which are accounted for by 3 mutations within mitochondrial complex I subunit–encoding genes in the mtDNA (mtLHON). Here, we resolve the enigma of LHON in the absence of pathogenic mtDNA mutations. We describe biallelic mutations in a nuclear encoded gene, DNAJC30, in 33 unsolved patients from 29 families and establish an autosomal recessive mode of inheritance for LHON (arLHON), which to date has been a prime example of a maternally inherited disorder. Remarkably, all hallmarks of mtLHON were recapitulated, including incomplete penetrance, male predominance, and significant idebenone responsivity. Moreover, by tracking protein turnover in patient-derived cell lines and a DNAJC30-knockout cellular model, we measured reduced turnover of specific complex I N-module subunits and a resultant impairment of complex I function. These results demonstrate that DNAJC30 is a chaperone protein needed for the efficient exchange of complex I subunits exposed to reactive oxygen species and integral to a mitochondrial complex I repair mechanism, thereby providing the first example to our knowledge of a disease resulting from impaired exchange of assembled respiratory chain subunits.

Authors

Sarah L. Stenton, Natalia L. Sheremet, Claudia B. Catarino, Natalia A. Andreeva, Zahra Assouline, Piero Barboni, Ortal Barel, Riccardo Berutti, Igor Bychkov, Leonardo Caporali, Mariantonietta Capristo, Michele Carbonelli, Maria L. Cascavilla, Peter Charbel Issa, Peter Freisinger, Sylvie Gerber, Daniele Ghezzi, Elisabeth Graf, Juliana Heidler, Maja Hempel, Elise Heon, Yulya S. Itkis, Elisheva Javasky, Josseline Kaplan, Robert Kopajtich, Cornelia Kornblum, Reka Kovacs-Nagy, Tatiana D. Krylova, Wolfram S. Kunz, Chiara La Morgia, Costanza Lamperti, Christina Ludwig, Pedro F. Malacarne, Alessandra Maresca, Johannes A. Mayr, Jana Meisterknecht, Tatiana A. Nevinitsyna, Flavia Palombo, Ben Pode-Shakked, Maria S. Shmelkova, Tim M. Strom, Francesca Tagliavini, Michal Tzadok, Amelie T. van der Ven, Catherine Vignal-Clermont, Matias Wagner, Ekaterina Y. Zakharova, Nino V. Zhorzholadze, Jean-Michel Rozet, Valerio Carelli, Polina G. Tsygankova, Thomas Klopstock, Ilka Wittig, Holger Prokisch

×

Figure 3

DNAJC30 mutations result in impaired repair of specific subunits of mitochondrial complex I.

Options: View larger image (or click on image) Download as PowerPoint

DNAJC30 mutations result in impaired repair of specific subunits of mit...
(A) The structure of mitochondrial complex I (CI) (30), depicted by module and respective protein. (B) Mitochondrial CI structure colored by the mean degree of subunit turnover in 12 hours in control fibroblast cell lines (n = 7) and patient fibroblast cell lines (n = 6) depicted as a percentage. The mean data are provided in Supplemental Table 15 and the individual experiments are depicted in Supplemental Tables 11–14. (C) The DNAJC30 interacting partners in CI according to the BioPlex database highlighted on the CI structure. The interaction partners in the N-module (NDUFV3, NDUFS4, NDUFS6, and NDUFA7) account for 4 of the 5 CIHIGH subunits, defined as subunits with >25% turnover in 12 hours in the control fibroblast cell lines. (D) Turnover measurement of CIHIGH subunits (n = 5) and (E) CIMOD subunits (n = 5) in 12 hours in control (n = 7), arLHON (n = 6), and mtLHON patient (n = 3, m.3460G>A in MT-ND1, m.11778G>A in MT-ND4, and m.14484T>C in MT-ND6) fibroblast cell lines, and control (n = 1) and DNAJC30-KO (n = 1) HEK293 cell lines. arLHON patients demonstrate a defect in CIHIGH (control mean 33.6% ± 11.2% SD, patient mean 16.8% ± 5.5% SD) and CIMOD (control mean 18.3% ± 5.7% SD, patient mean 12.5% ± 3.9% SD) subunits. The defective turnover of CIHIGH subunits is shown to be specific to arLHON (CIHIGH subunits, control mean 33.6% ± 11.2% SD, mtLHON mean 33.7% ± 13.7% SD). The DNAJC30-KO HEK293 cell line demonstrates a defect in CIHIGH (control mean 48.7% ± 8.3% SD, KO mean 31.0% ± 11.6% SD) and CIMOD (control mean 36.6% ± 8.9% SD, KO mean 24.5% ± 7.5% SD) subunits. Data depicted as the mean ± SD; 2-sided Student’s t test, P values corrected for multiple comparisons to the control (Dunnett’s test). *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001. NS, not significant. A complete summary of the data is provided in Supplemental Table 10 and the experiment is depicted in Supplemental Tables 10–15 and 17.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts